BIOBIJOU Co.,Ltd. (KOSDAQ:489460)

BIOBIJOU Statistics

Total Valuation

BIOBIJOU has a market cap or net worth of KRW 234.09 billion. The enterprise value is 224.99 billion.

Market Cap	234.09B
Enterprise Value	224.99B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

BIOBIJOU has 15.04 million shares outstanding.

Current Share Class	15.04M
Shares Outstanding	15.04M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.97%
Owned by Institutions (%)	4.61%
Float	5.11M

Valuation Ratios

The trailing PE ratio is 24.70.

PE Ratio	24.70
Forward PE	n/a
PS Ratio	7.90
PB Ratio	7.56
P/TBV Ratio	7.59
P/FCF Ratio	507.74
P/OCF Ratio	419.27
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.66, with an EV/FCF ratio of 487.99.

EV / Earnings	31.30
EV / Sales	7.59
EV / EBITDA	22.66
EV / EBIT	24.38
EV / FCF	487.99

Financial Position

The company has a current ratio of 4.58, with a Debt / Equity ratio of 0.08.

Current Ratio	4.58
Quick Ratio	3.53
Debt / Equity	0.08
Debt / EBITDA	0.24
Debt / FCF	5.18
Interest Coverage	20.77

Financial Efficiency

Return on equity (ROE) is 33.86% and return on invested capital (ROIC) is 19.32%.

Return on Equity (ROE)	33.86%
Return on Assets (ROA)	17.55%
Return on Invested Capital (ROIC)	19.32%
Return on Capital Employed (ROCE)	29.72%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.90
Inventory Turnover	2.84

Taxes

In the past 12 months, BIOBIJOU has paid 1.79 billion in taxes.

Income Tax	1.79B
Effective Tax Rate	19.95%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	18,596.40
200-Day Moving Average	n/a
Relative Strength Index (RSI)	35.50
Average Volume (20 Days)	188,353

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BIOBIJOU had revenue of KRW 29.63 billion and earned 7.19 billion in profits. Earnings per share was 630.08.

Revenue	29.63B
Gross Profit	14.82B
Operating Income	9.23B
Pretax Income	8.98B
Net Income	7.19B
EBITDA	9.93B
EBIT	9.23B
Earnings Per Share (EPS)	630.08

Balance Sheet

The company has 11.49 billion in cash and 2.39 billion in debt, giving a net cash position of 9.10 billion or 605.03 per share.

Cash & Cash Equivalents	11.49B
Total Debt	2.39B
Net Cash	9.10B
Net Cash Per Share	605.03
Equity (Book Value)	30.95B
Book Value Per Share	2,588.75
Working Capital	24.15B

Cash Flow

In the last 12 months, operating cash flow was 558.34 million and capital expenditures -97.29 million, giving a free cash flow of 461.05 million.

Operating Cash Flow	558.34M
Capital Expenditures	-97.29M
Free Cash Flow	461.05M
FCF Per Share	30.65

Margins

Gross margin is 50.01%, with operating and profit margins of 31.14% and 24.26%.

Gross Margin	50.01%
Operating Margin	31.14%
Pretax Margin	30.30%
Profit Margin	24.26%
EBITDA Margin	33.50%
EBIT Margin	31.14%
FCF Margin	1.56%

Dividends & Yields

BIOBIJOU does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	3.07%
FCF Yield	0.20%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BIOBIJOU has an Altman Z-Score of 2.78 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.78
Piotroski F-Score	3